Zinbryta approved by FDA for relapsing forms of multiple sclerosis

Daclizumab (Zinbryta) has been approved as a patient-injected, once-monthly treatment for adults with relapsing forms of multiple sclerosis (MS), according to the Food and Drug Administration....
Source: Clinical Neurology News - Category: Neurology Source Type: news